1. Home
  2. CVRX vs NPFD Comparison

CVRX vs NPFD Comparison

Compare CVRX & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • NPFD
  • Stock Information
  • Founded
  • CVRX 2000
  • NPFD 2021
  • Country
  • CVRX United States
  • NPFD United States
  • Employees
  • CVRX N/A
  • NPFD N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NPFD Trusts Except Educational Religious and Charitable
  • Sector
  • CVRX Health Care
  • NPFD Finance
  • Exchange
  • CVRX Nasdaq
  • NPFD Nasdaq
  • Market Cap
  • CVRX 419.8M
  • NPFD 453.8M
  • IPO Year
  • CVRX 2021
  • NPFD N/A
  • Fundamental
  • Price
  • CVRX $17.62
  • NPFD $18.76
  • Analyst Decision
  • CVRX Strong Buy
  • NPFD
  • Analyst Count
  • CVRX 7
  • NPFD 0
  • Target Price
  • CVRX $17.00
  • NPFD N/A
  • AVG Volume (30 Days)
  • CVRX 213.8K
  • NPFD 64.7K
  • Earning Date
  • CVRX 01-27-2025
  • NPFD 01-01-0001
  • Dividend Yield
  • CVRX N/A
  • NPFD 6.28%
  • EPS Growth
  • CVRX N/A
  • NPFD N/A
  • EPS
  • CVRX N/A
  • NPFD N/A
  • Revenue
  • CVRX $47,255,000.00
  • NPFD N/A
  • Revenue This Year
  • CVRX $31.78
  • NPFD N/A
  • Revenue Next Year
  • CVRX $26.42
  • NPFD N/A
  • P/E Ratio
  • CVRX N/A
  • NPFD N/A
  • Revenue Growth
  • CVRX 34.38
  • NPFD N/A
  • 52 Week Low
  • CVRX $6.40
  • NPFD $14.50
  • 52 Week High
  • CVRX $29.23
  • NPFD $18.07
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 76.79
  • NPFD 49.68
  • Support Level
  • CVRX $13.82
  • NPFD $18.70
  • Resistance Level
  • CVRX $17.72
  • NPFD $18.90
  • Average True Range (ATR)
  • CVRX 0.88
  • NPFD 0.21
  • MACD
  • CVRX 0.49
  • NPFD 0.02
  • Stochastic Oscillator
  • CVRX 98.09
  • NPFD 76.54

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.

Share on Social Networks: